Abstract:Objective To investigate the effect of continuous veno-venous hemofiltration(CVVH) in the treatment of acute severe hyponatremia. Methods Six patients with acute severe hyponatremia were studied, including 5 males and 1 female, aged 48.5(25-61) years. Clinical manifestations of hyponatremia included confusion (6/6), drowsiness(3/6), and delirium (3/6). The course of hyponatremia before the initiation of CVVH was 45-48 hours. AN69, AV600, FH66 and HF1200 hemofilters were applied and changed every 24 hours. The ultrafiltration rate was 2 000 ml/h, with a blood flow rate of 200-250 ml/min, and the substitute fluid was infused by a pre-dilution route. Low molecular weight heparin was used for anticoagulation. Results The average treatment duration of CVVH was 59.7(45.6-86) hours. All the patients survived and tolerated CVVH well. During CVVH, the serum sodium increased significantly from (101.2±4.2)mmol/L before CVVH, to (115.0±2.7)mmol/L at the 6th hour of CVVH, (129.2±4.1)mmol/L at the 24th hour, and (140.3±1.6)mmol/L at the 48th hour of CVVH; with the correction rate of serum sodium controlled at (2.5±0.4)mmol·L -1·h -1 over the first 24 hours,(1.2±0.1)mmol·L -1·h -1 for the first 48th hour, and the correction rate of (0.82±0.10)mmol·L -1·h -1. The sodium concentrations in the replacement solution were (16.0±6.0)mmol/L higher than the serum sodium concentration at 0 hour, (11.6±4.3)mmol/L higher at 4th hour, (5.5±5.1)mmol/L higher at 24th hour, and (0.75±0.96)mmol/L higher at 48th hour of CVVH. After CVVH, the serum osmolarity increased significantly, from (216.7±7.4)mOsm/kgH 2O pre-CVVH, to (245.0±5.5)mOsm/kgH 2O at 6th hour, with a correction rate of (5.16±0.81) mOsm·kgH 2O -1·h -1; (272.7±7.1)mOsm/kgH 2O at 24th hour, with a correction rate of (2.33±0.28) mOsm·kgH 2O -1·h -1; and (295.0±4.2)mOsm/kgH 2O at 48th hour, with a correction rate of (1.63±0.20) mOsm·kgH 2O -1·h -1.The Glasgow scores and APACHEⅡ scores improved significantly as compared to pretreatment. Conclusion CVVH is effective in the treatment of acute severe hyponatremia, and could be considered as a treatment option because of its slow and continuous nature. A low-sodium replacement solution should be prepared to minimize its sodium concentration difference from the serum concentration. We recommend that the serum sodium concentration be corrected at an average rate of (2.50±0.14) mmol·L -1·h -1 at 6h, (1.2±0.1)mmol·L -1·h -1 at 24h and (0.82±0.10) mmol·L -1·h -1 at 48h.

Correcting hyponatremia by fluid sodium modulation in continuous renal replacement therapy with regional citrate anticoagulation

Sterile water and regional citrate anticoagulation: A simple CRRT strategy for safe correction of severe hyponatraemia

Treatment of severe hyponatremia with continuous renal replacement therapy: A case and review of corrective strategies

Application of regional citrate anticoagulation (RCA) in continuous renal replacement therapy (CRRT) in patients with high risk of bleeding

Hyponatremia in Critically Ill Patients Due to Continuous Venovenous Hemofiltration With Diluted Sodium Citrate

High sodium continuous veno-venous hemodialysis with regional citrate anticoagulation and online dialysate generation in patients with acute liver failure and cerebral edema

Regional citrate anticoagulation and influence of recirculation on ionized calcium levels in the circuit

Optimized Calcium Supplementation Approach in Post-Dilution CVVHDF Using Regional Citrate Anticoagulation

Protocolized Regional Citrate Anticoagulation during Continuous Renal Replacement Therapy: A Single Center Experience

Optimizing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation: Insights from the ORCA Trial—A Retrospective Study on 10 Years of Practice

Continuous Renal Replacement Therapy for the Management of Acid-Base and Electrolyte Imbalances in Acute Kidney Injury.

Measurement of the Concentration of Citrate in Human Biofluids in Patients Undergoing Continuous Renal Replacement Therapy Using Regional Citrate Anticoagulation: Application of a Two-Step Enzymatic Assay

Comparison of Anticoagulant Effect of Low-Molecular-Weight Heparin Sodium and Sodium Citrate on Patients with Severe Acute Kidney Injury Treated by Continuous Renal Replacement Therapy

CaCl2-Citrate Regional Anticoagulation with Continuous Veno-Venous Haemodialysis Leads to Unwanted Chloride Loading Compared to Continuous Veno-Venous Hemofiltration with Systemic Anticoagulation

Automated Regional Citrate Anticoagulation System Based on Individualized Dosing Models in Nonliver Failure Patients Undergoing PIRRT Therapy

Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance

Automated Regional Citrate Anticoagulation Based on Online Monitoring of Ionized Calcium Concentration: Proof of Concept.

Calcium Supplementation in CVVH Using Regional Citrate Anticoagulation

Optimized Calcium Supplementation Approach for Regional Citrate Anticoagulation.

Continuous Veno-Venous Hemofiltration in Treatment of Acute Severe Hyponatremia:A Report of 6 Cases

Hyponatremia - Treatment standard 2024